학술논문
Fournier's Gangrene: Evaluation of Patient Outcomes Using Clinical Data and Prognostic Biomarkers
ORIGINAL ARTICLE
ORIGINAL ARTICLE
Document Type
Report
Author
Source
Journal of the College of Physicians and Surgeons Pakistan. March 2023, Vol. 33 Issue 3, p275, 6 p.
Subject
Language
English
ISSN
1022-386X
Abstract
INTRODUCTION Fournier's gangrene (FG) is an infectious disease characterised by necrotizing fasciitis of the external genitalia and perianal region. Although not very common, FG plays an important part in surgical [...]
Objective: To find out the outcomes of Fournier's gangrene (FG) patients using clinical data and prognostic biomarkers based on the current literature. Study Design: Descriptive study. Place and Duration of the Study: Department of General Surgery, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey, from January 2018, to January 2022. Methodology: Patients who were diagnosed with and treated for FG were included in the study. Patients younger than 18 years of age, those with missing hospital records and postoperative follow-up data, those with benign diseases related to the perianal or anal region, and those with other malignant diseases were excluded from the study. Patients' demographic, clinical, and laboratory data, including the calculated systemic immune-inflammation index (SII) and pan-immune-inflammation values (PIV) were obtained retrospectively from the medical records. Variables were analysed using SPSS statistics software, version 25.0. The value of p Conclusion: SII and PIV had no statistically significant interactions with FG. Key Words: Fournier's gangrene, Systemic immune-inflammation index, Pan-immune- inflammation value, Colostomy, Albumin.
Objective: To find out the outcomes of Fournier's gangrene (FG) patients using clinical data and prognostic biomarkers based on the current literature. Study Design: Descriptive study. Place and Duration of the Study: Department of General Surgery, University of Health Sciences, Gulhane Training and Research Hospital, Ankara, Turkey, from January 2018, to January 2022. Methodology: Patients who were diagnosed with and treated for FG were included in the study. Patients younger than 18 years of age, those with missing hospital records and postoperative follow-up data, those with benign diseases related to the perianal or anal region, and those with other malignant diseases were excluded from the study. Patients' demographic, clinical, and laboratory data, including the calculated systemic immune-inflammation index (SII) and pan-immune-inflammation values (PIV) were obtained retrospectively from the medical records. Variables were analysed using SPSS statistics software, version 25.0. The value of p Conclusion: SII and PIV had no statistically significant interactions with FG. Key Words: Fournier's gangrene, Systemic immune-inflammation index, Pan-immune- inflammation value, Colostomy, Albumin.